CJC OPEN
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Low Socioeconomic Status Is Associated with Reduced Access to Natriuretic Peptide Testing in the Outpatient Setting: A Population-based Evaluation.
7:390-401.
2025
-
Economic Burden of Heart Failure Hospitalizations in Canada: A Population-based Study..
7:279-286.
2025
-
Development of a Novel Risk-Prediction Tool for Emergency Department Patients with Symptoms of Coronary Artery Disease: A Research Study Protocol
2025
-
Effectiveness of Anti-Inflammatory Agents to Prevent Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Network Meta-Analysis..
7:35-45.
2025
-
Management of Patients with Myocardial Injury After Noncardiac Surgery: A Retrospective Chart Review..
7:103-109.
2025
-
Patient Preferences in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Screening and ICD Implantation: Canadian ARVC Registry Substudy..
7:27-34.
2025
-
Rhythm vs Rate Control Strategies for Perioperative Atrial Fibrillation After Noncardiac Surgery: A Systematic Review and Meta-analysis
2025
-
The Canadian Heart Failure (CAN-HF) Registry: A Canadian Multicentre, Retrospective Study of Outpatients with Heart Failure..
7:1-9.
2025
-
The Evolution of Head-Upright Tilt-Table Testing in Toronto, Ontario, Canada: 2014-2024
2025
-
“Is This Thing On?: Measuring Technology Self-Efficacy Influence on Cardiac Rehabilitation Patients’ Adoption of a Virtual Care Platform
2025
-
Temporal Trends in the Management Practices of Clinically Important Perioperative Atrial Fibrillation After Noncardiac Surgery..
6:1363-1371.
2024
-
Effect of Prehospital Digital Electrocardiogram Transmission on Revascularization Delays and Mortality in ST-Elevation Myocardial Infarction Patients: Systematic Review and Meta-Analysis..
6:1199-1206.
2024
-
An Innovative Patient-Centred Approach to Heart Failure Management: The Best Care Heart Failure Integrated Disease-Management Program.
6:989-1000.
2024
-
An Innovative Patient-Centred Approach to Heart Failure Management: The Best Care Heart Failure Integrated Disease-Management Program.
6:989-1000.
2024
-
Integration of Women’s Cardiovascular Health Content Into Healthcare Provider Education: Results of a Rapid Review and National Survey.
6:463-472.
2024
-
The Canadian Women’s Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 8: Knowledge Gaps and Status of Existing Research Programs in Canada.
6:220-257.
2024
-
“Comfort of Sitting at Home While Getting Information I Needed”: Experiences of Cardiac Patients Attending Virtual Cardiac Rehabilitation.
6:133-138.
2024
-
Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making.
5:881-890.
2023
-
CWHHA ATLAS: EPIDEMIOLOGY, DIAGNOSIS AND MANAGEMENT OF CARDIOVASCULAR DISEASES IN WOMEN Chapter 9: Summary of Current Status, Challenges, Opportunities, and Recommendations.
6:258-278.
2023
-
Characterizing Hypertension Specialist Care in Canada: A National Survey.
5:907-915.
2023
-
Benzodiazepine-Free Cardiac Anesthesia for Reduction of Postoperative Delirium (B-Free): A Protocol for a Multi-centre Randomized Cluster Crossover Trial.
5:691-699.
2023
-
Health Security Perceptions: Initial Psychometric Analysis of the Construct of Health Security in Chronic Illness Among Patients With a Cardiac Device.
5:704-708.
2023
-
Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer.
5:658-660.
2023
-
Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch Block.
5:611-618.
2023
-
Association Between the Pulmonary Artery Pulsatility Index and Prognosis in Pulmonary Arterial Hypertension: A Multicentre Study.
5:545-553.
2023
-
Factors Affecting Referral and Patient Access to Heart Function Clinics in Ontario: A Qualitative Study of Stakeholders.
5:421-428.
2023
-
Etiology of Acute Coronary Syndrome in a Young Woman: Can Intracoronary Imaging Help?.
5:345-347.
2023
-
Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of Care.
5:268-284.
2023
-
Centralized Triage of Suspected Coronary Artery Disease Using Coronary Computed Tomographic Angiography to Optimize the Diagnostic Yield of Invasive Angiography.
5:148-157.
2023
-
Impact of Rabeprazole on APO-Dabigatran Exposure in Healthy Volunteers.
5:1-7.
2023
-
Indigenous Women’s Perspectives on Heart Health and Well-being: A Scoping Review.
5:43-53.
2023
-
Use of Sacubitril/Valsar tan Prior to Primary Prevention Implantable Cardioverter Defibrillator Implantation.
5:93-98.
2023
-
Use of Sacubitril/Valsartan Prior to Primary Prevention Implantable Cardioverter Defibrillator Implantation.
5:93-98.
2023
-
Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL).
4:1074-1080.
2022
-
Incidence and Etiology of Poor Duplicate Ortho High-Sensitivity Cardiac Troponin I Results in a Community Hospital Emergency Department.
4:1100-1101.
2022
-
INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding.
4:996-1005.
2022
-
Presence of Macrotroponin for Over 2 Years in a Young Woman.
4:1012-1014.
2022
-
Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis.
4:840-847.
2022
-
The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies.
4:667-675.
2022
-
The Canadian Heart Failure (CAN-HF) Registry: A Canadian Multicentre, Retrospective Study of Inpatients With Heart Failure.
4:636-643.
2022
-
The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment.
4:589-608.
2022
-
High-Dose Thiamine Supplementation in Older Patients With Heart Failure: A Pilot Randomized Controlled Crossover Trial (THIAMINE-HF).
4:532-539.
2022
-
Rhythm Control Vs Rate Control in a Contemporary Ambulatory Atrial Fibrillation Cohort: Post Hoc Analysis of the IMPACT-AF Trial.
4:551-557.
2022
-
The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges.
4:568-576.
2022
-
The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 5: Sex- and Gender-Unique Manifestations of Cardiovascular Disease.
4:243-262.
2022
-
The Hospital at Home Model vs Routine Hospitalization for Acute Heart Failure: A Survey of Patients’ Preferences.
4:263-270.
2022
-
Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada From 2002 to 2018.
4:206-213.
2022
-
“Her Heart Matters”—Making Visible the Cardiac Pain Experiences of Women with Physical Disabilities and Heart Disease: A Qualitative Study.
4:214-222.
2022
-
Association of Sex With Stroke and Bleeding Risk of Apixaban and Rivaroxaban in Elderly Atrial Fibrillation Patients Using Propensity Score Weights.
4:56-64.
2022
-
Short-term and Long-term Risk of Stroke in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: Systematic Review and Meta-analysis.
4:85-96.
2022
-
60 Years After the First Woman Cardiac Surgeon: We Still Need More Women in Cardiac Surgery.
3:S89-S94.
2021
-
A Prevention Approach to Reducing Gender-Based Harassment and Discrimination in Cardiovascular Medicine.
3:S9-S11.
2021
-
Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study.
3:1419-1427.
2021
-
Assessment of Radiation-Induced Malfunction in Cardiac Implantable Electronic Devices.
3:1438-1443.
2021
-
Equity and Game-Theory Strategies to Promote Gender Diversity and Inclusion in an Academic Health Science Centre.
3:S53-S61.
2021
-
Incidence and Predictors of Heart Failure in Patients With Atrial Fibrillation.
3:1482-1489.
2021
-
Incorporating a Women’s Cardiovascular Health Curriculum Into Medical Education.
3:S187-S191.
2021
-
National Trends of Gender Disparity in Canadian Cardiovascular Society Guideline Authors, 2001-2020.
3:S12-S18.
2021
-
Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study.
3:1463-1470.
2021
-
Trends of Sex Differences in Clinical Outcomes After Myocardial Infarction in the United States.
3:S19-S27.
2021
-
Medical Therapy Following Urgent/Emergent Revascularization in Peripheral Artery Disease Patients (Canadian Acute Limb Ischemia Registry [CANALISE I]).
3:1325-1332.
2021
-
Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis.
3:1372-1382.
2021
-
An Evaluation of Cardiology Virtual Care During the COVID-19 Pandemic.
3:1294-1299.
2021
-
The Association of Atrial Fibrillation Before Percutaneous Coronary Intervention With 1-Year Outcome in ST-Elevation Myocardial Infarction Patients.
3:1221-1229.
2021
-
The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data.
3:1238-1248.
2021
-
Immigrants, Ethnicity, and Adherence to Secondary Cardiac Prevention Therapy: A Substudy of the ISLAND Trial.
3:913-923.
2021
-
Important Differences Between Manufacturers When Transitioning From a Contemporary Cardiac Troponin Assay to a High-Sensitivity Cardiac Troponin Assay.
3:841-842.
2021
-
Association Between Perioperative Atrial Fibrillation and Long-term Risks of Stroke and Death in Noncardiac Surgery: Systematic Review and Meta-analysis.
3:666-674.
2021
-
Surveillance for Outcomes Selected as Atrial Fibrillation Quality Indicators in Canada: 10-Year Trends in Stroke, Major Bleeding, and Heart Failure.
3:609-618.
2021
-
Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study.
3:267-275.
2021
-
Outcomes and Safety of Fluoroless Catheter Ablation for Atrial Fibrillation.
3:303-310.
2021
-
Admission High-Sensitivity Cardiac Troponin vs a Biochemical Score for Predicting Mortality in Patients With COVID-19.
3:130-131.
2021
-
One-Year Costs Associated with Hospitalizations Due to Aortic Stenosis in Canada.
3:82-90.
2021
-
Accuracy of Physicians in Differentiating Type 1 and Type 2 Myocardial Infarction Based on Clinical Information.
2:577-584.
2020
-
Early Observations During the COVID-19 Pandemic in Cardiac Catheterization Procedures for ST-Elevation Myocardial Infarction Across Ontario.
2:678-683.
2020
-
Is It Only Takotsubo Syndrome? Cardiac MRI and a Case of Delayed ST-Elevation.
2:722-725.
2020
-
Patients and Health Care Providers Identify Important Outcomes for Research on Pregnancy and Heart Disease.
2:454-461.
2020
-
Sex, Gender, and Equity in Cardiovascular Medicine, Surgery, and Science in Canada: Challenges, Successes, and Opportunities for Change.
2:522-529.
2020
-
The Canadian Alliance for Healthy Hearts and Minds: How Well Does It Reflect the Canadian Population?.
2:599-609.
2020
-
The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network.
2:652-662.
2020
-
Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada.
2:321-327.
2020
-
Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial.
2:354-359.
2020
-
Remote Ambulatory Cardiac Monitoring Before and After Transcatheter Aortic Valve Replacement.
2:416-419.
2020
-
Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Catheter Ablation or Antiarrhythmic Drug Therapy: A Systematic Review and Meta-analysis.
2:286-295.
2020
-
High-Sensitivity Cardiac Troponin I vs a Clinical Chemistry Score for Predicting All-Cause Mortality in an Emergency Department Population.
2:296-302.
2020
-
Inclusion of People Poststroke in Cardiac Rehabilitation Programs in Canada: A Missed Opportunity for Referral.
2:195-206.
2020
-
Management of Acute Decompensated Heart Failure in the Cardiac Intensive Care Unit: The Importance of Co-management With a Heart Failure Specialist..
2:229-235.
2020
-
Quality Improvement High-Sensitivity Cardiac Troponin I vs a Clinical Chemistry Score for Predicting All-Cause Mortality in an Emergency Department Population.
2:296-302.
2020
-
The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey.
2:151-160.
2020
-
The Burden of Atherosclerotic Cardiovascular Disease in South Asians Residing in Canada: A Reflection From the South Asian Heart Alliance.
1:271-281.
2019
-
“All About Us”: Indigenous Data Analysis Workshop—Capacity Building in the Canadian Alliance for Healthy Hearts and Minds First Nations Cohort.
1:282-288.
2019
-
An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter.
1:198-205.
2019
-
Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm.
1:190-197.
2019
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)